Related topics

BioScrip: 3Q Earnings Snapshot

November 6, 2018

DENVER (AP) _ BioScrip Inc. (BIOS) on Tuesday reported a loss of $8.2 million in its third quarter.

The Denver-based company said it had a loss of 9 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.

The infusion and home care services company posted revenue of $181 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $171.1 million.

BioScrip expects a full-year loss of 32 cents to 26 cents per share, with revenue in the range of $710 million to $720 million.

The company’s shares closed at $2.81. A year ago, they were trading at $2.07.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIOS at https://www.zacks.com/ap/BIOS

Update hourly